Skip to main content
Clinical Trials/NCT02906345
NCT02906345
Unknown
Not Applicable

"Analyses on the Effectiveness and Technical Optimization of Therapeutic Plasma Exchange for Patients With Septic Shock, With Special Emphasis on Influencing the Kidney, Liver and Nervous System Through the Extracorporeal Therapy"

University of Rostock1 site in 1 country30 target enrollmentSeptember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Organ Failure
Sponsor
University of Rostock
Enrollment
30
Locations
1
Primary Endpoint
SOFA score ≥ 2 Punkte
Last Updated
6 years ago

Overview

Brief Summary

Therapeutic plasma exchange (TPE) should used for patients with septic shock in a controlled, prospective study focusing on the organ functions of the patients.

Detailed Description

Therapeutic plasma exchange (TPE) should used for patients with septic shock in a controlled, prospective study. Investigators will study three groups: 1. untreated control group; 2. TPE group, plasma separation carried out by filtration; 3. TPE group, plasma separation carried out by centrifugation. All treated patients should treated two (minimal) to five times by TPE, depending on the need of norephinephrine for the therapy. For each session 40 ml/kg body weight plasma should be exchange. Fluid resuscitation will be done with fresh frozen plasma. The study will focusing on the organ functions of the patients, especially liver-, kidney- and nervous function and also displayed in the SOFA score on study days 3 and 7.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
August 2022
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Rostock
Responsible Party
Principal Investigator
Principal Investigator

Dr. Martin Sauer, MD

PD Dr. med. habil.; MD

University of Rostock

Eligibility Criteria

Inclusion Criteria

  • Septic shock, beginning of shock \< 24 hours

Exclusion Criteria

  • Participation in an another clinical trial within the last 30 days
  • Participation in this study at an earlier date
  • Simultaneous participation in another clinical trial
  • Pregnancy
  • Unpredictable Bleeding (over 2 erythrocyte concentrates daily)
  • Polyneuropathy (known before the beginning of sepsis)

Outcomes

Primary Outcomes

SOFA score ≥ 2 Punkte

Time Frame: day 7

SOFA: Sepsis-related Organ Failure Assessment score

Secondary Outcomes

  • 28-day survival(day 28)
  • Hospital survival(1 year)

Study Sites (1)

Loading locations...

Similar Trials